메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 30, Issue 1, 2012, Pages 114-115
FOLFIRINOX: A great leap forward, but for whom?
Author keywords

[No Author keywords available]
Indexed keywords

CAMPTOTHECIN; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN;
EID: 84855547515     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.4056     Document Type: Letter
Times cited : (5)
References (7)
  • 1
    • 80053592994 scopus 로고    scopus 로고
    • FOLFIRINOX: A small step or a great leap forward?
    • Ko AH: FOLFIRINOX: A small step or a great leap forward? J Clin Oncol 29:3727-3729, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 3727-3729
    • Ko, A.H.1
  • 2
    • 79955921754 scopus 로고    scopus 로고
    • FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
    • Conroy T, Desseigne F, Ychou M, et al: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817-1825, 2011
    • (2011) N Engl J Med , vol.364 , pp. 1817-1825
    • Conroy, T.1    Desseigne, F.2    Ychou, M.3
  • 3
    • 59849115856 scopus 로고    scopus 로고
    • Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer
    • Farrell JJ, Elsaleh H, Garcia M, et al: Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology 136:187-195, 2009
    • (2009) Gastroenterology , vol.136 , pp. 187-195
    • Farrell, J.J.1    Elsaleh, H.2    Garcia, M.3
  • 4
    • 33645731188 scopus 로고    scopus 로고
    • Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine
    • Giovannetti E, Del Tacca M, Mey V, et al: Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res 66:3928-3935, 2006
    • (2006) Cancer Res , vol.66 , pp. 3928-3935
    • Giovannetti, E.1    Del Tacca, M.2    Mey, V.3
  • 5
    • 65349163336 scopus 로고    scopus 로고
    • Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma
    • Maréchal R, Mackey JR, Lai R, et al: Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. Clin Cancer Res 15:2913-2919, 2009
    • (2009) Clin Cancer Res , vol.15 , pp. 2913-2919
    • Maréchal, R.1    Mackey, J.R.2    Lai, R.3
  • 6
    • 6044267987 scopus 로고    scopus 로고
    • The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma
    • DOI 10.1158/1078-0432.CCR-04-0224
    • Spratlin J, Sangha R, Glubrecht D, et al: The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. Clin Cancer Res 10:6956-6961, 2004 (Pubitemid 39383046)
    • (2004) Clinical Cancer Research , vol.10 , Issue.20 , pp. 6956-6961
    • Spratlin, J.1    Sangha, R.2    Glubrecht, D.3    Dabbagh, L.4    Young, J.D.5    Dumontet, C.6    Cass, C.7    Lai, R.8    Mackey, J.R.9
  • 7
    • 71349084183 scopus 로고    scopus 로고
    • Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3′-deoxy-3′- fluorothymidine
    • Paproski RJ, Young JD, Cass CE: Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3′-deoxy-3′-fluorothymidine. Biochem Pharmacol 79:587-595, 2010
    • (2010) Biochem Pharmacol , vol.79 , pp. 587-595
    • Paproski, R.J.1    Young, J.D.2    Cass, C.E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.